| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000246898.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.000598907 |
Sensitive |
| ENSG00000246898.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.003232839 |
Sensitive |
| ENSG00000246898.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.008585882 |
Sensitive |